Evolution of drug therapy in patients with resectable gastric and esophageal‑gastric junction cancer

Evolution of drug therapy in patients with resectable gastric and esophageal‑gastric junction cancer

Gastric cancer (GC) is the fifth most common malignant neoplasm in the world among all malignant tumors. Currently, the “gold” standard of treatment for patients with non‑metastatic cancer of the stomach and esophageal–gastric junction is surgical treatment, which is complemented by perioperative ch...

Full description

Saved in:
Bibliographic Details
Main Authors: M. V. Sedova, M. A. Batov, V. S. Tretyak, A. A. Kolomeytseva, V. M. Khomyakov, N. N. Volchenko, A. A. Fedenko, A. D. Kaprin
Format: Article
Language:Russian
Published: QUASAR, LLC 2023-06-01
Series:Исследования и практика в медицине
Subjects:
gastric cancer
perioperative chemotherapy
immunotherapy
target therapy
Online Access:https://www.rpmj.ru/rpmj/article/view/920
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items